N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide

C29H51N5O9 — CID 162966191

IUPACN-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide
SMILESCCCCCCCC(=O)N[C@@H]1C(=O)N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)O[C@@H]1C
InChIInChI=1S/C29H51N5O9/c1-7-9-10-11-12-13-21(37)32-24-18(6)43-29(42)23(17(5)8-2)34-27(40)22(16(3)4)33-26(39)20(15-36)30-25(38)19(14-35)31-28(24)41/h16-20,22-24,35-36H,7-15H2,1-6H3,(H,30,38)(H,31,41)(H,32,37)(H,33,39)(H,34,40)/t17-,18+,19+,20-,22+,23+,24-/m0/s1
InChIKeyJZGSMCBRGCMNJV-JYJJNEMUSA-N
MW613.75 g/mol
LogP-0.60
Rot. Bonds12

About N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide

N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide (PubChem CID 162966191) has the molecular formula C29H51N5O9 and a molecular weight of 613.75 g/mol. Its IUPAC name is N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide.

Molecular Properties

Compound NameN-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide
PubChem CID162966191
Molecular FormulaC29H51N5O9
Molecular Weight613.75 g/mol
Exact Mass613.37
IUPAC NameN-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide
SMILESCCCCCCCC(=O)N[C@@H]1C(=O)N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)O[C@@H]1C
InChIInChI=1S/C29H51N5O9/c1-7-9-10-11-12-13-21(37)32-24-18(6)43-29(42)23(17(5)8-2)34-27(40)22(16(3)4)33-26(39)20(15-36)30-25(38)19(14-35)31-28(24)41/h16-20,22-24,35-36H,7-15H2,1-6H3,(H,30,38)(H,31,41)(H,32,37)(H,33,39)(H,34,40)/t17-,18+,19+,20-,22+,23+,24-/m0/s1
InChIKeyJZGSMCBRGCMNJV-JYJJNEMUSA-N
XLogP-0.60
TPSA212.26 Ų
H-Bond Donors7
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms43
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500613.75
LogP ≤ 5-0.60
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide?
The IUPAC name of N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide (CID 162966191) is N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide.
What is the SMILES notation for N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide?
The canonical SMILES for N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide is CCCCCCCC(=O)N[C@@H]1C(=O)N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](C(C)C)C(=O)N[C@H]([C@@H](C)CC)C(=O)O[C@@H]1C.
What is the InChIKey of N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide?
The InChIKey is JZGSMCBRGCMNJV-JYJJNEMUSA-N. The full InChI is InChI=1S/C29H51N5O9/c1-7-9-10-11-12-13-21(37)32-24-18(6)43-29(42)23(17(5)8-2)34-27(40)22(16(3)4)33-26(39)20(15-36)30-25(38)19(14-35)31-28(24)41/h16-20,22-24,35-36H,7-15H2,1-6H3,(H,30,38)(H,31,41)(H,32,37)(H,33,39)(H,34,40)/t17-,18+,19+,20-,22+,23+,24-/m0/s1.
What are the key properties of N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide?
N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide has a molecular weight of 613.75 g/mol, XLogP of -0.60, 12 rotatable bonds, 7 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,6R,9S,12R,15S,16R)-3-[(2S)-butan-2-yl]-9,12-bis(hydroxymethyl)-16-methyl-2,5,8,11,14-pentaoxo-6-propan-2-yl-1-oxa-4,7,10,13-tetrazacyclohexadec-15-yl]octanamide is sourced from PubChem (CID 162966191), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).